HENDERA
831152
Fujian Nebula Electronics.,Ltd
300648
HNAC Technology
300490
4
Guangzhou LBP Medicine Science & Technology
688393
5
TFL
873152
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 65.57%155.94M | 347.69%40.04M | 276.57%30.92M | 12.23%62.69M | 5.31%22.3M | 102.97%94.18M | -74.48%8.94M | 91.87%8.21M | 614.86%55.86M | 2,980.54%21.17M |
Net income from continuing operations | 222.63%36.85M | -151.79%-1.29M | 1,297.93%35.36M | 126.22%4.09M | 90.58%-1.32M | 66.30%-30.05M | 117.19%2.48M | 83.07%-2.95M | 35.03%-15.59M | 57.98%-13.99M |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | -138.46%-1.29M | ---- | ---- | ---- | ---- |
Depreciation and amortization | -12.71%88.65M | -4.21%22.91M | -30.08%17.57M | -1.39%24.32M | -14.37%23.85M | 11.24%101.56M | -31.22%23.92M | 16.52%25.13M | 43.76%24.67M | 56.45%27.85M |
Deferred tax | -139.29%-23.95M | -69.61%644K | -169.20%-26.33M | 123.34%482K | 544.33%1.25M | -2.57%-10.01M | -49.45%2.12M | -427.28%-9.78M | 47.88%-2.07M | 96.53%-282K |
Other non cash items | 28.63%15.58M | -58.83%1.39M | -73.47%1.04M | 385.81%8.01M | 62.22%5.14M | -6.76%12.11M | 105.41%3.38M | 599.29%3.92M | -78.37%1.65M | 0.22%3.17M |
Change In working capital | 47.27%-53.22M | 91.59%-3.88M | 44.01%-21.56M | -73.57%4.14M | 0.27%-31.93M | 14.00%-100.94M | -109.22%-46.08M | 25.57%-38.51M | 154.52%15.67M | -115.29%-32.02M |
-Change in receivables | 21.98%-45.39M | -352.63%-720K | 98.50%-325K | -28.95%-18.58M | -14.99%-25.76M | 48.00%-58.17M | 103.01%285K | -18.23%-21.64M | 68.91%-14.41M | 40.69%-22.4M |
-Change in payables and accrued expense | 92.53%-601K | 112.48%3.34M | -332.25%-6.41M | -34.88%19.88M | -69.28%-17.42M | -169.16%-8.05M | -77.95%-26.8M | 94.86%-1.48M | -8.67%30.53M | -146.52%-10.29M |
-Change in other current assets | 308.87%28.93M | 226.81%7.84M | 103.88%577K | 194.24%7.2M | 179.95%13.32M | -2,005.17%-13.85M | -166.06%-6.18M | -1,421.05%-14.88M | 118.71%2.45M | 146.53%4.76M |
-Change in other current liabilities | 6.30%-19.38M | -31.10%-5.51M | -4.34%-4.38M | 35.03%-5.01M | 1.99%-4.49M | -23.58%-20.68M | -19.86%-4.2M | 8.88%-4.2M | -84.75%-7.7M | -2.78%-4.58M |
-Change in other working capital | -8,424.87%-16.79M | 3.89%-8.83M | -399.00%-11.03M | -86.47%651K | 391.45%2.41M | -179.76%-197K | -173.13%-9.19M | 434.36%3.69M | 240.55%4.81M | -85.13%491K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 65.57%155.94M | 347.69%40.04M | 276.57%30.92M | 12.23%62.69M | 5.31%22.3M | 102.97%94.18M | -74.48%8.94M | 91.87%8.21M | 614.86%55.86M | 2,980.54%21.17M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -8.28%-50.41M | -21.40%-12.87M | 12.23%-12.1M | -717.48%-12.65M | 47.17%-12.79M | 59.63%-46.56M | 47.05%-10.6M | 58.62%-13.79M | 105.83%2.05M | 9.70%-24.21M |
Capital expenditure reported | -5.68%-50.49M | -10.88%-12.95M | 12.23%-12.1M | -20.98%-12.65M | -7.89%-12.8M | 58.62%-47.78M | 41.50%-11.68M | 58.69%-13.79M | 70.33%-10.45M | 55.91%-11.86M |
Net PPE purchase and sale | -4.71%81K | 1.35%75K | --0 | --0 | -40.00%6K | -47.53%85K | 219.35%74K | --0 | -98.70%1K | -88.51%10K |
Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | --1M | ---- | ---- | ---- | ---- |
Net investment purchase and sale | --0 | --0 | --0 | --0 | --0 | --138K | --0 | --0 | --12.5M | ---12.36M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -8.28%-50.41M | -21.40%-12.87M | 12.23%-12.1M | -717.48%-12.65M | 47.17%-12.79M | 59.63%-46.56M | 47.05%-10.6M | 58.62%-13.79M | 105.83%2.05M | 9.70%-24.21M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -216.55%-53.76M | 28.96%-6.22M | -3,619.82%-24.4M | -110.81%-13.07M | -630.53%-10.07M | 1.42%-16.98M | -150.26%-8.75M | 68.37%-656K | -182.93%-6.2M | 85.43%-1.38M |
Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net common stock issuance | -161.66%-28.61M | 61.11%-2.93M | ---7.47M | -233.85%-11.34M | ---6.86M | -34.23%-10.93M | ---7.54M | --0 | ---3.4M | --0 |
Net other financing activities | -315.70%-25.15M | -170.59%-3.29M | -2,480.49%-16.93M | 38.37%-1.73M | -133.07%-3.21M | 33.38%-6.05M | 65.27%-1.21M | 68.37%-656K | -27.89%-2.8M | -4.31%-1.38M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -216.55%-53.76M | 28.96%-6.22M | -3,619.82%-24.4M | -110.81%-13.07M | -630.53%-10.07M | 1.42%-16.98M | -150.26%-8.75M | 68.37%-656K | -182.93%-6.2M | 85.43%-1.38M |
Net cash flow | ||||||||||
Beginning cash position | 13.09%364.3M | 7.73%395.57M | 7.96%400.5M | 15.12%363.59M | 13.09%364.3M | -24.99%322.14M | 11.36%367.2M | 2.49%370.96M | -19.48%315.84M | -24.99%322.14M |
Current changes in cash | 68.94%51.77M | 246.63%20.95M | -66.99%-5.59M | -32.47%36.98M | 91.20%-570K | 135.57%30.64M | -223.95%-14.29M | 89.24%-3.35M | 285.39%54.76M | 82.51%-6.48M |
Effect of exchange rate changes | -11.59%473K | -93.87%25K | 257.45%655K | -118.13%-66K | -178.77%-141K | 148.42%535K | -58.11%408K | 62.04%-416K | 146.79%364K | 187.32%179K |
End cash Position | 14.34%416.55M | 14.34%416.55M | 7.73%395.57M | 7.96%400.5M | 15.12%363.59M | 13.09%364.3M | 13.09%364.3M | 11.36%367.2M | 2.49%370.96M | -19.48%315.84M |
Free cash flow | 127.24%105.45M | 1,091.65%27.09M | 437.15%18.81M | 10.22%50.05M | 2.02%9.5M | 167.18%46.4M | -118.11%-2.73M | 80.83%-5.58M | 265.59%45.41M | 133.69%9.31M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |